NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Clinical trial NCT00667082 · COMPLETED

Trial details

NCT number: NCT00667082
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Pancreatic Cancer Melanoma Lymphoma Multiple Myeloma

Start date: 2008-03-01
Primary completion: 2010-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.